Advanced SearchSearch Tips
Male Breast Cancer: 20 Years Experience of a Tertiary Hospital from the Middle Black Sea Region of Turkey
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Male Breast Cancer: 20 Years Experience of a Tertiary Hospital from the Middle Black Sea Region of Turkey
Serarslan, Alparslan; Gursel, Bilge; Okumus, Nilgun Ozbek; Meydan, Deniz; Sullu, Yurdanur; Gonullu, Guzin;
  PDF(new window)
Background: Male breast cancer is a rare neoplasm, and its treatments are based on those of female breast cancer. This study aimed to analyze 20 years of male breast cancer clinical characteristics and treatment results from the Middle Black Sea Region of Turkey. Materials and Methods: A retrospective analysis of 16 male breast cancer patients treated in our tertiary hospital between 1994 and 2014 was performed. Epidemiologic data, tumor characteristics, and treatments were recorded and compared with 466 female breast cancer ((premenopausal; n
Epidemiology;male breast cancer;pathology;treatment outcome;Turkey;
 Cited by
Adibelli ZH, Oztekin O, Postaci H, Uslu A (2009). The diagnostic accuracy of mammography and ultrasound in the evaluation of male breast disease: a new algorithm. Breast Care, 4, 255-9. crossref(new window)

Adibelli ZH, Oztekin O, Gunhan-Bilgen I, et al (2010). Imaging characteristics of male breast disease. Breast J, 16, 510-8. crossref(new window)

Arslan UY, Oksuzoglu B, Ozdemir N, et al (2012). Outcome of non-metastatic male breast cancer: 118 patients. Med Oncol, 29, 554-60. crossref(new window)

Atahan L, Yildiz F, Selek U, Sari S, Gurkaynak M (2006). Postoperative radiotherapy in the treatment of male breast carcinoma: a single institute experience. J Natl Med Assoc, 98, 559-63.

Bagley CS, Wesley MN, Young RC, Lippman ME (1987). Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol, 10, 55-60. crossref(new window)

Chakravarthy A, Kim CR (2002). Post-mastectomy radiation in male breast cancer. Radiother Oncol, 65, 99-103. crossref(new window)

Clarke M, Collins R, Darby S, et al (2005). Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet, 366, 2087-106. crossref(new window)

Cutuli B (2007). Strategies in treating male breast cancer. Expert Opin Pharmacother, 8, 193-202. crossref(new window)

Cutuli B, Le-Nir CC, Serin D, et al (2010). Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev Oncol Hematol, 73, 246-54. crossref(new window)

Dabakuyo TS, Dialla O, Gentil J, et al (2012). Breast cancer in men in Cote d'Or (France): epidemiological characteristics, treatments and prognostic factors. Eur J Cancer Care (Engl), 21, 809-16. crossref(new window)

Engin K, Unsal M (1993). Cancer of the male breast: the Turkish experience. J Surg Oncol, 53, 128-32. crossref(new window)

Erkin O, Ardahan M (2014). Breast cancer and breast selfexamination in stamps history. Lokman Hekim Journal, 4, 22-8.

Fentiman IS, Fourquet A, Hortobagyi GN (2006). Male breast cancer. Lancet, 367, 595-604. crossref(new window)

Fentiman IS (2009). Male breast cancer: a review. Ecancermedicalscience, 3, 140.

Fogh S, Hirsch AE, Langmead JP, et al (2011). Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer. Clin Breast Cancer, 11, 39-45. crossref(new window)

Gennari R, Curigliano G, Jereczek-Fossa BA, et al (2004). Male breast cancer: a special therapeutic problem. Anything new? (Review). Int J Oncol, 24, 663-70.

Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN (2004). Breast carcinoma in men: a population-based study. Cancer, 101, 51-7. crossref(new window)

Giordano SH (2005). A review of the diagnosis and management of male breast cancer. Oncologist, 10, 471-9. crossref(new window)

Gomez-Raposo C, Zambrana Tevar F, Sereno Moyano M, Lopez Gomez M, Casado E (2010). Male breast cancer. Cancer Treat Rev, 36, 451-7. crossref(new window)

Goss PE, Reid C, Pintilie M, Lim R, Miller N (1999). Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer, 85, 629-39. crossref(new window)

Gradishar WJ, Anderson BO, Balassanian R, et al (2015). Breast cancer version 2.2015. J Natl Compr Canc Netw, 13, 448-75.

Gunhan-Bilgen I, Bozkaya H, Ustun E, Memis A (2002). Male breast disease: clinical, mammographic, and ultrasonographic features. Eur J Radiol, 43, 246-55. crossref(new window)

Hayashi H, Kimura M, Yoshimoto N, et al (2009). A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment. Breast Cancer, 16, 136-40. crossref(new window)

Haydaroglu A, Dubova S, Ozsaran Z, et al (2005). Breast cancer in Ege University “evaluation of 3897 cases”. J Breast Health, 1, 6-11.

Hayes TG (2009). Pharmacologic treatment of male breast cancer. Expert Opin Pharmacother, 10, 2499-510. crossref(new window)

Nordman IC, Dalley DN (2008). Breast cancer in men: should aromatase inhibitors become first-line hormonal treatment? Breast J, 14, 562-9. crossref(new window)

Ozmen V (2014). Breast cancer in Turkey: clinical and histopathological characteristics (Analysis of 13.240 Patients). J Breast Health, 10, 98-105. crossref(new window)

Patten DK, Sharifi LK, Fazel M (2013). New approaches in the management of male breast cancer. Clin Breast Cancer, 13, 309-14. crossref(new window)

Reis LO, Dias FG, Castro MA, Ferreira U (2011). Male breast cancer. Aging Male, 14, 99-109. crossref(new window)

Ribeiro GG, Swindell R, Harris M, Banerjee SS, Cramer A (1996). A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. The Breast, 5, 141-6. crossref(new window)

Selcukbiricik F, Tural D, Aydogan F, et al (2013). Male breast cancer: 37-year data study at a single experience center in Turkey. J Breast Cancer, 16, 60-5. crossref(new window)

Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. crossref(new window)

Sipetic-Grujicic SB, Murtezani ZH, Neskovic-Konstatinovic ZB, et al (2014). Multivariate analysis of prognostic factors in male breast cancer in Serbia. Asian Pac J Cancer Prev, 15, 3233-8. crossref(new window)

Somerville P (1952). Carcinoma of the male breast; a report of 19 cases and a review of the literature. Br J Surg, 39, 296-303. crossref(new window)

Yildirim E, Berberoglu U (1998). Male breast cancer: a 22-year experience. Eur J Surg Oncol, 24, 548-52. crossref(new window)

Zygogianni AG, Kyrgias G, Gennatas C, et al (2012). Male breast carcinoma: epidemiology, risk factors and current therapeutic approaches. Asian Pac J Cancer Prev, 13, 15-9. crossref(new window)